Anzeige
Mehr »
Donnerstag, 05.06.2025 - Börsentäglich über 12.000 News
Kupfer wird knapp! Jetzt mischen sich Medien ein - und ein Explorer liefert die Story zur Fantasie
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiNovo Nordisk signs on to support ADA's obesity advocacy division
MiBayer gains key FDA expansion for fast-rising prostate cancer drug Nubeqa
MiCDC vaccine expert resigns amid shifting COVID guidance: Reuters
MiNovartis marketing breach sparks PMCPA call for companies to be 'on high alert'
MiBiosynthesis specialist and Narcan ingredient maker Antheia reels in $56M in series C funding
DiASCO: J&J highlights Rybrevant-Lazcluze combo in 'Breathtaking Moments' lung cancer campaign high over Chicago skyline
DiAgenus transfers pair of CA production plants to Zydus as part of $141M partnership
MoScience-led storytelling takes center stage in pharma communications
MoEndo maps out Men's Health Month awareness, education drive
MoWith Opella proceeds burning a hole in its pocket, Sanofi snaps up Blueprint Medicines for $9.1B
MoTheravance hands off the last of its Trelegy royalties to GSK for $225M
MoModerna's next-gen COVID shot gets FDA backing with some limitations
MoRegulatory tracker: Eton wins FDA nod for Khindivi, the first hydrocortisone oral solution
FrAfter holding out, bluebird bio investors get on board with sale to Carlyle, SK Capital
FrAbbVie flies the W against cancer with Chicago Cubs partnership, ASCO corporate campaign
FrSenator grills Makary over FDA's ability to regulate drug ads after OPDP cuts
FrAstellas organizes action week to connect patients to advocacy groups
FrAkeso, Summit's ivonescimab delayed progression by 48% in certain lung cancers in first global phase 3 readout
29.05.'Hanging on by our fingernails': Stealth CEO questions efficiency behind FDA rejection of rare disease drug
29.05.Sanofi spices up Type 1 diabetes awareness with sponsorship of new UK girl group
29.05.Alcon gains first FDA prescription drug nod since Novartis split, scoring with drops for dry eye disease
29.05.Drugmakers, trade groups and others voice concerns with pharma-specific tariffs
29.05.AACE Pharma slammed with FDA warning letter for contract manufacturer's shortfalls
29.05.Pfizer again found to have discredited pharma industry with COVID-19 vaccine tweets
29.05.Daiichi, Merck pull HER3-DXd filing at FDA after confirmatory trial misses survival endpoint